Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by bullman246on Aug 19, 2020 12:39pm
239 Views
Post# 31429025

RE:RE:RE:RE:RE:New Core1 Website and Presentation - Check It Out!

RE:RE:RE:RE:RE:New Core1 Website and Presentation - Check It Out!I actually think that it is a good thing that management owns so many shares. With their own money at take, I want them to have plenty of skin in the game soi our losses also become theis as well.

Since we have not traded since 7/14, I am getting increasungly concerned.  If Joel net his target 7/31 deadline, why are we still not trading?

I'm not sure how I feel about the company's new highly experimental direction towards psyedelics and mushrooms, with Cannastrips as the delivery system. Especially since magic mushrooms are illegal in Canada. 

I also highly question why Joel doesn't mention selling CBD and CBD/THC versions of Cannastrips in Europe, given his already established coonnections via MOTA (see recent MOTA news reports). This is something that could potentially take place qiote quickly and easily. So why not?
Bullboard Posts